Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of AgeBEJON, Philip; LUSINGU, John; DEMOITIE, Marie-Ange et al.The New England journal of medicine. 2008, Vol 359, Num 24, pp 2521-2532, issn 0028-4793, 12 p.Article

Development of a transmission-blocking malaria vaccine: Progress, challenges, and the path forwardNUNES, Julia K; WOODS, Colleen; BIRKETT, Ashley J et al.Vaccine. 2014, Vol 32, Num 43, pp 5531-5539, issn 0264-410X, 9 p.Article

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trialOLOTU, Ally; LUSINGU, John; VANSADIA, Preeti et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 2, pp 102-109, issn 1473-3099, 8 p.Article

Safety and efficacy of the RTS,S/AS01_E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trialKWAKU POKU ASANTE; ABDULLA, Salim; SALIM, Nahya et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 10, pp 741-749, issn 1473-3099, 9 p.Article

Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in InfantsABDULLA, Salim; OBERHOLZER, Rolf; SALIM, Nahya et al.The New England journal of medicine. 2008, Vol 359, Num 24, pp 2533-2544, issn 0028-4793, 12 p.Article

Immunization Safety in US Print Media, 1995―2005HUSSAIN, Hamidah; OMER, Saad B; MANGANELLO, Jennifer A et al.Pediatrics (Evanston). 2011, Vol 127, issn 0031-4005, S100-S106, SUP1Article

Association of vaccine-related attitudes and beliefs between parents and health care providersMERGLER, Michelle J; OMER, Saad B; HALSEY, Neal et al.Vaccine. 2013, Vol 31, Num 41, pp 4591-4595, issn 0264-410X, 5 p.Article